South Texas Money Management’s West Pharmaceutical WST Stock Holding History

South Texas Money Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$302K	Buy	+2,129	New	+$293K	0.01%	299

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

South Texas Money Management's WST Position: Q3 2019 in Review

South Texas Money Management opened a new position in West Pharmaceutical (WST) in Q3 2019: 2,129 shares worth $302K. The stake represents 0.01% of the portfolio and ranks #299 among its holdings.

406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

South Texas Money Management held 2,129 shares of West Pharmaceutical worth $302K as of Q3 2019.
West Pharmaceutical was a new South Texas Money Management position in Q3 2019.
West Pharmaceutical made up 0.01% of South Texas Money Management's portfolio in Q3 2019, its #299 holding.
406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on South Texas Money Management's 13F filing for Q3 2019, filed 13 Nov 2019.